Kobo Biotech shareholding pattern
KOBO
2.89
0.13 (4.71%)Last updated on 20 Feb, 2026 | 15:16 IST
BUYSELL
Free Demat with Zero AMC*
Summary
For Year 2025-26, Kobo Biotech reports the following shareholding: Total Promoters at 44.95%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 55.05%. This breakdown provides a quick snapshot of ownership distribution for Kobo Biotech in 2025-26.
Kobo Biotech FAQs
As of 02-2026, the promoter shareholding in Kobo Biotech stands at 44.95% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Kobo Biotech is 0% and 0% respectively.
The retail shareholding of the Kobo Biotech is 55.05%.
Changes in shareholding patterns of Kobo Biotech can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Kobo Biotech are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
